139 related articles for article (PubMed ID: 3014811)
41. Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis.
Zhou H; Wang H; Zhou D; Wang H; Wang Q; Zou S; Tu Q; Wu M; Hu H
Eur J Cancer; 2010 Apr; 46(6):1056-61. PubMed ID: 20202823
[TBL] [Abstract][Full Text] [Related]
42. Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma.
Coursaget P; Chiron JP; Barres JL; Barin F; Cottey P; Tortey E; Yvonnet B; Diop B; MBoup S; Diop-Mar I
IARC Sci Publ; 1984; (63):181-98. PubMed ID: 6085625
[TBL] [Abstract][Full Text] [Related]
43. Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study.
Seo SI; Choi HS; Choi BY; Kim HS; Kim HY; Jang MK
J Med Virol; 2014 Jan; 86(1):124-30. PubMed ID: 24127328
[TBL] [Abstract][Full Text] [Related]
44. Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area.
Lee SB; Kim KM; An J; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS
Liver Int; 2016 Sep; 36(9):1351-61. PubMed ID: 26913702
[TBL] [Abstract][Full Text] [Related]
45. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
Edamoto Y; Tani M; Kurata T; Abe K
Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
[TBL] [Abstract][Full Text] [Related]
46. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
Mwangi J; Gatei DG
East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
[TBL] [Abstract][Full Text] [Related]
47. The status of serum hepatitis B virus DNA in HBSAG-positive hepatocellular carcinoma.
Yu ML; Chuang WL; Chow TY; Chen SC; Lu SN; Lin ZY; Hsieh MY; Wang LY; Chang WY
Kaohsiung J Med Sci; 1996 Aug; 12(8):466-70. PubMed ID: 8774115
[TBL] [Abstract][Full Text] [Related]
48. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
49. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
Chen DS; Sung JL; Lai MY
Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
[TBL] [Abstract][Full Text] [Related]
50. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
51. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
52. Iron, ferritin, hepatitis B surface and core antigens in the livers of Chinese patients with hepatocellular carcinoma.
Zhou XD; DeTolla L; Custer RP; London WT
Cancer; 1987 Apr; 59(8):1430-7. PubMed ID: 3028601
[TBL] [Abstract][Full Text] [Related]
53. [Hepatitis B virus DNA detection by means of polymerase chain reaction in patients with chronic hepatitis and hepatocellular carcinoma].
Song Y; Pan W; Fan Z; Du P; Qi Z
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):220-2. PubMed ID: 15617333
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis of Schistosomiasis japonica infection coincident with hepatocellular carcinoma by fine-needle aspiration.
Chen HZ; Chuang SC; Hsieh FC; Lin LJ; Hung RM; Lee KT
Diagn Cytopathol; 2007 Nov; 35(11):722-4. PubMed ID: 17924411
[TBL] [Abstract][Full Text] [Related]
55. Non-B hepatocellular carcinoma: influence of age, sex, alcohol, family clustering, blood transfusion and chronic liver disease.
Yamada G; Mizuno M; Kinoyama S; Nishihara T; Okushin H; Hyodo I; Sakamoto Y; Nagashima H
Acta Med Okayama; 1984 Apr; 38(2):181-91. PubMed ID: 6328894
[TBL] [Abstract][Full Text] [Related]
56. Chronic hepatitis B virus infection in Asian countries.
Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
[TBL] [Abstract][Full Text] [Related]
57. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
58. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
[TBL] [Abstract][Full Text] [Related]
59. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan.
Tomimatsu M; Ishiguro N; Taniai M; Okuda H; Saito A; Obata H; Yamamoto M; Takasaki K; Nakano M
Cancer; 1993 Aug; 72(3):683-8. PubMed ID: 8192727
[TBL] [Abstract][Full Text] [Related]
60. IgM antibody to hepatitis B core antigen in Korean patients with hepatocellular carcinoma.
Sjogren MH; Lemon SM; Chung WK; Sun HS; Hoofnagle JH
Hepatology; 1984; 4(4):615-8. PubMed ID: 6204916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
